[ U.S. CDMRP – Neurotoxin Exposure Treatment Parkinson’s Program Early Investigator Research Award ]
Event details
| Date | 18.08.2020 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Neurotoxin Exposure Treatment Parkinson’s Program (NETP) Awards. The NETP Early Investigator Research Award supports neurotoxin exposure and treatment-related Parkinson’s disease research opportunities for investigators in the early stages of their careers, under the guidance of a designated Mentor(s). The Early Investigator is considered the Principal Investigator (PI) of the application and must exhibit strong potential for, and commitment to, pursuing a career as an investigator at the forefront of Parkinson’s disease research; however, the PI is not required to have previous Parkinson’s disease research experience. Applications must include at least one Mentor, appropriate to the proposed research project, who has experience in Parkinson’s disease research and mentoring as demonstrated by a record of active funding, recent publications, and successful mentorship.
To meet the intent of the award mechanism, applications must address one of the FY20 NETP Focus Areas, which are listed at the end of this announcement.
Funding: max. $400’000
Duration: 2 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. The investigator must be a postdoctoral or clinical fellow, instructor, or assistant professor within 10 years of advanced degree training or residency training completion.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of potential recommendation letter writers as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 18-Aug-2020, 5:00 p.m. EST
Full Application Deadline: 16-Sep-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-NETP-EIRA
Further information
FY20 NETP Focus Areas
To meet the intent of the award mechanism, applications must address one of the FY20 NETP Focus Areas, which are listed at the end of this announcement.
Funding: max. $400’000
Duration: 2 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. The investigator must be a postdoctoral or clinical fellow, instructor, or assistant professor within 10 years of advanced degree training or residency training completion.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of potential recommendation letter writers as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 18-Aug-2020, 5:00 p.m. EST
Full Application Deadline: 16-Sep-2020, 11:59 p.m. EST
Grants.gov Funding Opportunity Number: W81XWH-20-NETP-EIRA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-20-NETP-EIRA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
FY20 NETP Focus Areas
- Quantifiable gene - environment interactions and the risk for or progression of Parkinson’s disease following neurotoxin exposure.
- Basic biology of non-motor symptoms that could lead to the development of new treatments for Parkinson’s disease following neurotoxin exposure.
- System-level mechanism of dopamine refractory motor symptoms in Parkinson’s disease, including postural instability, freezing of gait, and treatment-associated dystonia, that could lead to development of new treatments in patients with neurotoxin exposure.
- Clinical and research application of digital health technology leading to development of new treatments for Parkinson’s disease in those individuals exposed to neurotoxins.
Practical information
- General public
- Free